GOT1 and pancreatic neoplasm: Researchers remodel glutamine metabolism in pancreatic cancer by increasing the expression of aspartate aminotransferase (GOT1) and decreasing glutamate dehydrogenase (GLUD1), thereby increasing flux through GOT1-dependent pathways.